Digital healthcare, medical information system, and medical data-related stocks showed mixed movements by stock on the morning of the 7th. C2Soft, EasyCareTech, and Vieworks are rising more than 3%, while Insung Information, Bluemtech, and Infinite Healthcare are weakening.

■ C2Soft, EasyCareTech, and Vieworks Rise Over 3%

As of the morning of the 7th, C2Soft is trading at 22,150 won, up 3.75% from the previous trading day. The stock opened at 21,350 won and rose to as high as 24,450 won during the session, with a low of 21,250 won.

EasyCareTech is also trading at 6,900 won, up 3.60%. It started at 6,660 won today and rose to 6,910 won during the session, moving near its high.

Vieworks, a medical imaging-related stock, is up 3.04% at 27,150 won. Its intraday high is 27,300 won.

In addition, Nanentech is up 1.20% at 4,215 won, and InBody is up 1.47% at 62,000 won. Medipost is up 0.56% at 8,970 won, and Bit Computer is up 0.53% at 3,795 won. Rsupport rose 0.40%, and Dynamic Solutions also gained 0.90%.

■ Insung Information, Bluemtech, and Infinite Healthcare Decline

Meanwhile, some digital healthcare-related stocks are declining. Insung Information is down 1.69% at 1,050 won, and Bluemtech is trading down 1.66% at 2,075 won. Infinite Healthcare fell 1.50% to 9,535 won.

CareLabs also dropped 1.15%, while JLK fell 0.64%, GC MedAI 0.48%, and Cha Biotech 0.37%. Macrogen and Softcen are also posting small declines.

■ Individual Companies' Business Progress Needs to Be Confirmed

The digital healthcare sector encompasses multiple business areas, including hospital information systems, medical imaging, telemedicine-based technology, medical AI, and health data analysis, so individual companies' stock price directions often diverge. Today as well, rather than all related stocks moving in unison, gains are being led by select names such as C2Soft, EasyCareTech, and Vieworks.

Looking ahead at stock price trends, it is necessary to also confirm actual business progress, such as individual companies' expansion of supply to medical institutions, new contracts, and performance in medical AI and data businesses.

[※ This article was written for the purpose of providing information on the domestic stock market and related stocks, and does not recommend the purchase or sale of specific stocks or guarantee investment returns. Stock prices can change rapidly depending on market conditions, and investment decisions and the resulting responsibility lie with the investor. This article was written with AI assistance.]